Upgrade to SI Premium - Free Trial

Boundless Bio (BOLD)

2.52 +0.04 (1.61%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 Boundless Bio, Inc. For: Jul 17 Filed by: TANG KEVIN July 21, 2026 7:39 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jul 14 Filed by: TANG KEVIN July 16, 2026 8:11 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jul 09 Filed by: TANG KEVIN July 13, 2026 7:06 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jul 06 Filed by: TANG KEVIN July 8, 2026 8:06 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jul 01 Filed by: GILLIS STEVEN July 6, 2026 5:45 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jul 01 Filed by: ARCH Venture Partners X Overage, L.P. July 6, 2026 5:43 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jun 30 Filed by: TANG KEVIN July 2, 2026 7:46 PM - SEC Filing Form SCHEDULE 13G Boundless Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC June 29, 2026 7:58 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jun 25 Filed by: TANG KEVIN June 29, 2026 7:56 PM - SEC Filing Form 3 Boundless Bio, Inc. For: Jun 25 Filed by: TANG KEVIN June 29, 2026 7:52 PM - SEC Filing These Emerging Companies Are Racing Toward Major Catalysts June 23, 2026 11:12 AM - StreetInsider Form 425 Boundless Bio, Inc. Filed by: Boundless Bio, Inc. June 23, 2026 8:35 AM - SEC Filing Form 8-K Boundless Bio, Inc. For: Jun 22 June 23, 2026 8:30 AM - SEC Filing Boundless Bio agrees to merge with Serapha Bio in all-stock deal June 23, 2026 7:30 AM - StreetInsider Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement June 23, 2026 7:30 AM - StreetInsider Next-Generation DNA Repair Therapies Open New Frontiers in Oncology June 22, 2026 8:30 AM - StreetInsider Form 8-K Boundless Bio, Inc. For: Jun 15 June 17, 2026 10:49 AM - SEC Filing Form 4 Boundless Bio, Inc. For: Jun 15 Filed by: Whiting Nancy June 15, 2026 7:41 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jun 15 Filed by: Lim Jonathan E June 15, 2026 7:36 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jun 15 Filed by: Christensen James June 15, 2026 7:32 PM - SEC Filing Form 4 Boundless Bio, Inc. For: Jun 15 Filed by: Lew Jennifer June 15, 2026 7:29 PM - SEC Filing Audentes Therapeutics (BOLD) Tops Q1 EPS by 20c May 8, 2026 8:15 AM - StreetInsider Form 10-Q Boundless Bio, Inc. For: Mar 31 May 8, 2026 7:11 AM - SEC Filing Form 8-K Boundless Bio, Inc. For: May 08 May 8, 2026 7:05 AM - SEC Filing Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights May 8, 2026 7:00 AM - Globe NewsWire Form ARS Boundless Bio, Inc. For: Dec 31 April 28, 2026 4:10 PM - SEC Filing Form DEFA14A Boundless Bio, Inc. April 28, 2026 4:05 PM - SEC Filing Form DEF 14A Boundless Bio, Inc. For: Jun 15 April 28, 2026 4:00 PM - SEC Filing Full Article List